Atlas FDA

WRAPSODY® Cell-Impermeable Endoprosthesis

FDA premarket approval P240023 · decided 2024-12-19

Approval details

PMA number
P240023
Trade name
WRAPSODY® Cell-Impermeable Endoprosthesis
Generic name
System, endovascular graft, arteriovenous (AV) dialysis access circuit stenosis treatment
Applicant
Merit Medical Systems, Inc.
Date received
2024-06-26
Decision date
2024-12-19
Days to decision
176 days
Decision code
APPR
Product code
PFV
Advisory committee
Cardiovascular
Expedited review
No
Location
South Jordan, UT
Statement
Approval for Merit Medical Systems, Inc. WRAPSODY Cell-Impermeable Endoprosthesis. This device is indicated for use in hemodialysis patients for the treatment of stenosis or occlusion within the dialysis access outflow circuit, including stenosis or occlusion in the peripheral veins of individuals with an arteriovenous (AV) fistula or at the venous anastomosis of a synthetic AV graft.

Class III intelligence, same tools

PMAs share the API, exports and alerts with 510(k) data - watch an applicant and hear about every approval.

510(k) clearances by this applicant

RecordFirmDate
FlexTract Deflectable-Rotational Dilator Sheath Set (K261310)Merit Medical Systems, Inc.2026-07-27
PreludeSYNC™ Radial Compression Device (K262086)Merit Medical Systems, Inc.2026-07-22
StatSeal Disc (K254073)Merit Medical Systems, Inc.2026-05-13
STAR RF Ablation System (K251802)Merit Medical Systems, Inc.2026-02-13
SCOUT MD Surgical Guidance System (K252892)Merit Medical Systems, Inc.2025-12-19
Merit Syringe (K250853)Merit Medical Systems, Inc.2025-11-04
Resilience Fully Covered Esophageal Stent System (K251265)Merit Medical Systems, Inc.2025-07-23
Prelude Wave Hydrophilic Sheath Introducer (K250909)Merit Medical Systems, Inc.2025-04-25